PsyLabs: Valuation, Funding & Investors
PsyLabs is a producer of psychedelic active pharmaceutical ingredients, operating from an ISO 22000-certified facility in Southern Africa. The company holds federal licenses to cultivate, extract, and export psychedelic compounds, including psilocybin and ibogaine, to legal medical and research markets.
Leadership & Board
- Current Number of Employees
- 16
- Current LinkedIn Followers
- 1,407
Latest Estimated Valuation
- Total Amount Raised
- $4M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $4M
- Latest Funding Round
- Investment
Employee Trend
PsyLabs had 16 employees as of November 2, 2026. The number of employees increased by 0 (0.00%) week-over-week.
16Latest Employee Count
0(0.00%)Week-Over-Week Change
Social Trend
PsyLabs had 1,407 followers as of November 2, 2026. The number of followers decreased by 3 (0.21%) week-over-week.
1,407Latest Followers Count
3(-0.21%)Week-Over-Week Change
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Nov 03, 2025 | Investment | $3.50M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| Psyence BioMed | Investment |
Similar Companies
A snapshot of private companies similar to PsyLabs, helping you discover and navigate related company profiles.
Related News and Analysis
